Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
Union Health Minister says India’s healthcare model blends traditional wisdom with modern science, backed by Ayushman Bharat and Janaushadhi expansion
Opioid dependence remains a major driver of death and disease worldwide
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
He brings extensive cross-functional expertise built through leadership roles
Subscribe To Our Newsletter & Stay Updated
